PEACHI header v5 FP7-gen-RGB EU flag

Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections

A collaborative project financed by the EC Framework Programme 7

Recent Publications by PEACHI consortium members

Swadling L et al., Sci Transl Med. 2014 Nov 5;6(261):261ra153 – A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

 

Kelly C et al., Eur J Immunol. 2015 Jan;45(1):309-16 – Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes

 

Capone S et al., Mol Ther. 2014 May;22(5):1039-47 – Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates

 

Hancock G et al., PLoS Pathog. 2015 Feb 27;11(2) – Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses

 

Borthwick N et al., Mol Ther. 2014 Feb;22(2):464-75 – Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

 

von Delft A et al., Gut 2015 Jun; 0:1–12 – The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.

 

Ewer et al., Curr Opin Immunol 2016 Jun 7; 41: 47-54 - Viral vectors as vaccine platforms: from immunology to impact.